Brief: Labcorp Completes Acquisition Of Select Assets Of BioReference Health's Innovative Oncology And Related Clinical Testing Services Businesses
15/09/2025 13:45
Sept 15 (Reuters) - Labcorp Holdings Inc LH.N: LABCORP COMPLETES ACQUISITION OF SELECT ASSETS OF BIOREFERENCE HEALTH'S INNOVATIVE ONCOLOGY AND RELATED CLINICAL TESTING SERVICES BUSINESSES LABCORP: PURCHASE PRICE FOR TRANSACTION IS UP TO $225 MILLION Source text: ID:nPn6v7yQfa Further company coverage: LH.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on OPKO Health
See all newsOpko Health, Inc. Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
US RESEARCH ROUNDUP-Bank7, Goldman Sachs, Morgan Stanley
Deals of the day-Mergers and acquisitions
US STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons